101
Views
25
CrossRef citations to date
0
Altmetric
Original Research

Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy

, , , , , , , & show all
Pages 5729-5742 | Published online: 02 Nov 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Angelica Jimenez-Rosales, Stefani Cortes-Camargo & Pedro Estanislao Acuña-Avila. (2024) Minireview: biocompatibility of engineered biomaterials, their interaction with the host cells, and evaluation of their properties. International Journal of Polymeric Materials and Polymeric Biomaterials 73:1, pages 45-60.
Read now

Articles from other publishers (24)

Ashish Garg, Vaibhav Kumar S. Gawali, Rupesh K. Gautam, Rajeev K. Singla & Sumel Ashique. 2023. Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective. Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective 255 279 .
Yeye Hu, Wei Zhang, Xiaozhong Chu, Aoran Wang, Ziliang He, Chuan-Ling Si & Weicheng Hu. (2023) Dendritic cell-targeting polymer nanoparticle-based immunotherapy for cancer: A review. International Journal of Pharmaceutics 635, pages 122703.
Crossref
Kiarash Saleki & Nima Rezaei. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology 1 25 .
Qiang Xu, Ye Chen, Yuan Jin, Zhiyu Wang, Haoru Dong, Andreas M. Kaufmann, Andreas E. Albers & Xu Qian. (2022) Advanced Nanomedicine for High-Risk HPV-Driven Head and Neck Cancer. Viruses 14:12, pages 2824.
Crossref
Fernando Torres Andón, Sergio Leon, Aldo Ummarino, Esther Redin, Paola Allavena, Diego Serrano, Clément Anfray & Alfonso Calvo. (2022) Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists. Biomedicines 10:7, pages 1590.
Crossref
Kai Li, Zhicheng Zhang, Yu Mei, Mengmeng Li, Qingzhu Yang, Qiong Wu, Huanjie Yang, Liangcan He & Shaoqin Liu. (2022) Targeting the innate immune system with nanoparticles for cancer immunotherapy. Journal of Materials Chemistry B 10:11, pages 1709-1733.
Crossref
Ji Eun Won, Youngseon Byeon, Tae In Wi, Chan Mi Lee, Ju Hyeong Lee, Tae Heung Kang, Jeong-Won Lee, YoungJoo Lee, Yeong-Min Park & Hee Dong Han. (2022) Immune checkpoint silencing using RNAi-incorporated nanoparticles enhances antitumor immunity and therapeutic efficacy compared with antibody-based approaches. Journal for ImmunoTherapy of Cancer 10:2, pages e003928.
Crossref
Anuja Jain, Shikha Mittal, Lokesh P. Tripathi, Ruth Nussinov & Shandar Ahmad. (2022) Host-pathogen protein-nucleic acid interactions: A comprehensive review. Computational and Structural Biotechnology Journal 20, pages 4415-4436.
Crossref
Zhang Ruirui, Jian He, Ximei Xu, Shengxian Li, Hongmei Peng, Zhiming Deng & Yong Huang. (2021) PLGA-based drug delivery system for combined therapy of cancer: research progress. Materials Research Express 8:12, pages 122002.
Crossref
Ji Eun Won, Tae In Wi, Chan Mi Lee, Ju Hyeong Lee, Tae Heung Kang, Jeong-Won Lee, Byung Cheol Shin, YeongJoo Lee, Yeong-Min Park & Hee Dong Han. (2021) NIR irradiation-controlled drug release utilizing injectable hydrogels containing gold-labeled liposomes for the treatment of melanoma cancer. Acta Biomaterialia 136, pages 508-518.
Crossref
Ramar Thangam, Kapil D. Patel, Heemin Kang & Ramasamy Paulmurugan. (2021) Advances in Engineered Polymer Nanoparticle Tracking Platforms towards Cancer Immunotherapy—Current Status and Future Perspectives. Vaccines 9:8, pages 935.
Crossref
Giulio Giustarini, Andrea Pavesi & Giulia Adriani. (2021) Nanoparticle-Based Therapies for Turning Cold Tumors Hot: How to Treat an Immunosuppressive Tumor Microenvironment. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Haoru Dong, Xiuchun Li, Mengsi Cai, Chi Zhang, Weiqi Mao, Ying Wang, Qian Xu, Mayun Chen, Liangxing Wang & Xiaoying Huang. (2021) Integrated bioinformatic analysis reveals the underlying molecular mechanism of and potential drugs for pulmonary arterial hypertension. Aging 13:10, pages 14234-14257.
Crossref
Leila Pourtalebi Jahromi, Mohammad‐Ali Shahbazi, Aziz Maleki, Amir Azadi & Hélder A. Santos. (2021) Chemically Engineered Immune Cell‐Derived Microrobots and Biomimetic Nanoparticles: Emerging Biodiagnostic and Therapeutic Tools. Advanced Science 8:8, pages 2002499.
Crossref
Neelam Thakur, Saloni Thakur, Sharmistha Chatterjee, Joydeep Das & Parames C. Sil. (2020) Nanoparticles as Smart Carriers for Enhanced Cancer Immunotherapy. Frontiers in Chemistry 8.
Crossref
Jingjing Liu, Lei Miao, Jiying Sui, Yanyun Hao & Guihua Huang. (2020) Nanoparticle cancer vaccines: Design considerations and recent advances. Asian Journal of Pharmaceutical Sciences 15:5, pages 576-590.
Crossref
Asmita Banstola, Jee-Heon Jeong & Simmyung Yook. (2020) Immunoadjuvants for cancer immunotherapy: A review of recent developments. Acta Biomaterialia 114, pages 16-30.
Crossref
Peter Abdou, Zejun Wang, Qian Chen, Amanda Chan, Daojia R. Zhou, Vivienne Gunadhi & Zhen Gu. (2020) Advances in engineering local drug delivery systems for cancer immunotherapy. WIREs Nanomedicine and Nanobiotechnology 12:5.
Crossref
Lingjie Ke, Pingqiang Cai, Yun‐Long Wu & Xiaodong Chen. (2020) Polymeric Nonviral Gene Delivery Systems for Cancer Immunotherapy. Advanced Therapeutics 3:6, pages 1900213.
Crossref
Tuan Hiep Tran, Thi Thu Phuong Tran, Duy Hieu Truong, Hanh Thuy Nguyen, Tung Thanh Pham, Chul Soon Yong & Jong Oh Kim. (2019) Toll-like receptor-targeted particles: A paradigm to manipulate the tumor microenvironment for cancer immunotherapy. Acta Biomaterialia 94, pages 82-96.
Crossref
Ji Eun Won, Yeongseon Byeon, Tae In Wi, Jae Myeong Lee, Tae Heung Kang, Jeong Won Lee, Byung Cheol Shin, Hee Dong Han & Yeong-Min Park. (2019) Enhanced Antitumor Immunity Using a Tumor Cell Lysate-Encapsulated CO 2 -Generating Liposomal Carrier System and Photothermal Irradiation . ACS Applied Bio Materials 2:6, pages 2481-2489.
Crossref
Yeongseon Byeon, Jeong-Won Lee, Whan Soo Choi, Ji Eun Won, Ga Hee Kim, Min Gi Kim, Tae In Wi, Jae Myeong Lee, Tae Heung Kang, In Duk Jung, Young-Jae Cho, Hyung Jun Ahn, Byung Cheol Shin, Young Joo Lee, Anil K. Sood, Hee Dong Han & Yeong-Min Park. (2018) CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer. Cancer Research 78:21, pages 6247-6256.
Crossref
Flavia Fontana, Patrícia Figueiredo, Tomás Bauleth-Ramos, Alexandra Correia & Hélder A. Santos. (2018) Immunostimulation and Immunosuppression: Nanotechnology on the Brink. Small Methods 2:5, pages 1700347.
Crossref
Lijia Luo, Rui Shu & Aiguo Wu. (2017) Nanomaterial-based cancer immunotherapy. Journal of Materials Chemistry B 5:28, pages 5517-5531.
Crossref